Presidio Partners 2007, L.P.
CIK 0001405712 Name as filed on the most recent filing
Filed as Presidio Partners 2007, L.P. (3)· Cmea Ventures VII LP (28)
103 transaction lines · from 31 filings · filed 2014-02-12 to 2018-07-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Menlo Therapeutics Inc. 1 filings
- ISSUER Neos Therapeutics, Inc. 2 filings
- ISSUER Auspex Pharmaceuticals, Inc. 25 filings
- ISSUER Ardelyx, Inc. 3 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2014-10-29 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 279 disposed | 27.02 | 7,539.42 | Form 4, filing 0001209191-14-065571 | |
| 2014-10-28 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 10,725 disposed | 26.99 | 289,476.33 | Form 4, filing 0001209191-14-065281 | |
| 2014-10-28 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 275 disposed | 26.99 | 7,422.47 | Form 4, filing 0001209191-14-065281 | |
| 2014-10-27 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 3,413 disposed | 27.11 | 92,541.45 | Form 4, filing 0001209191-14-065281 | |
| 2014-10-27 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 87 disposed | 27.11 | 2,358.95 | Form 4, filing 0001209191-14-065281 | |
| 2014-10-24 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 10,628 disposed | 27.09 | 287,865.76 | Form 4, filing 0001209191-14-064938 | |
| 2014-10-24 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 272 disposed | 27.09 | 7,367.28 | Form 4, filing 0001209191-14-064938 | |
| 2014-10-23 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 5,460 disposed | 26.74 | 145,974.19 | Form 4, filing 0001209191-14-064938 | |
| 2014-10-23 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 140 disposed | 26.74 | 3,742.93 | Form 4, filing 0001209191-14-064938 | |
| 2014-10-06 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 178 disposed | 23.44 | 4,173.21 | Form 4, filing 0001209191-14-063333 | |
| 2014-10-06 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 6,931 disposed | 23.44 | 162,497.30 | Form 4, filing 0001209191-14-063333 | |
| 2014-10-06 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 6,931 disposed | 23.44 | 162,497.30 | Form 4, filing 0001209191-14-062531 | |
| 2014-10-06 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 178 disposed | 23.44 | 4,173.21 | Form 4, filing 0001209191-14-062531 | |
| 2014-09-05 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 8,678 disposed | 23.50 | 203,926.06 | Form 4, filing 0001209191-14-056967 | |
| 2014-09-05 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 222 disposed | 23.50 | 5,216.82 | Form 4, filing 0001209191-14-056967 | |
| 2014-09-04 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 16,283 disposed | 24.05 | 391,633.83 | Form 4, filing 0001209191-14-056967 | |
| 2014-09-04 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 417 disposed | 24.05 | 10,029.56 | Form 4, filing 0001209191-14-056967 | |
| 2014-09-03 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 312 disposed | 23.09 | 7,205.27 | Form 4, filing 0001209191-14-056988 | |
| 2014-09-03 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 12,188 disposed | 23.09 | 281,467.23 | Form 4, filing 0001209191-14-056988 | |
| 2014-09-03 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 12,188 disposed | 23.09 | 281,467.23 | Form 4, filing 0001209191-14-055892 | |
| 2014-09-03 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 312 disposed | 23.09 | 7,205.27 | Form 4, filing 0001209191-14-055892 | |
| 2014-09-02 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 255 disposed | 23.07 | 5,882.70 | Form 4, filing 0001209191-14-056988 | |
| 2014-09-02 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 9,945 disposed | 23.07 | 229,425.18 | Form 4, filing 0001209191-14-056988 | |
| 2014-09-02 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 9,945 disposed | 23.07 | 229,425.18 | Form 4, filing 0001209191-14-055892 | |
| 2014-09-02 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 255 disposed | 23.07 | 5,882.70 | Form 4, filing 0001209191-14-055892 | |
| 2014-08-29 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 8,483 disposed | 22.59 | 191,649.63 | Form 4, filing 0001209191-14-056987 | |
| 2014-08-29 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 217 disposed | 22.59 | 4,902.51 | Form 4, filing 0001209191-14-056987 | |
| 2014-08-29 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 8,483 disposed | 22.59 | 191,649.63 | Form 4, filing 0001209191-14-055603 | |
| 2014-08-29 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 217 disposed | 22.59 | 4,902.51 | Form 4, filing 0001209191-14-055603 | |
| 2014-08-28 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 305 disposed | 22.24 | 6,783.69 | Form 4, filing 0001209191-14-056986 | |
| 2014-08-28 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 11,895 disposed | 22.24 | 264,563.83 | Form 4, filing 0001209191-14-056986 | |
| 2014-08-28 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 11,895 disposed | 22.24 | 264,563.83 | Form 4, filing 0001209191-14-055054 | |
| 2014-08-28 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 305 disposed | 22.24 | 6,783.69 | Form 4, filing 0001209191-14-055054 | |
| 2014-08-27 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 435 disposed | 21.88 | 9,516.63 | Form 4, filing 0001209191-14-056986 | |
| 2014-08-27 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 16,965 disposed | 21.88 | 371,148.39 | Form 4, filing 0001209191-14-056986 | |
| 2014-08-27 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 16,965 disposed | 21.88 | 371,148.39 | Form 4, filing 0001209191-14-055054 | |
| 2014-08-27 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 435 disposed | 21.88 | 9,516.63 | Form 4, filing 0001209191-14-055054 | |
| 2014-08-26 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 6,143 disposed | 21.35 | 131,164.72 | Form 4, filing 0001209191-14-056985 | |
| 2014-08-26 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 157 disposed | 21.35 | 3,352.25 | Form 4, filing 0001209191-14-056985 | |
| 2014-08-26 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 6,143 disposed | 21.35 | 131,164.72 | Form 4, filing 0001209191-14-054856 | |
| 2014-08-26 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 157 disposed | 21.35 | 3,352.25 | Form 4, filing 0001209191-14-054856 | |
| 2014-08-25 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 135 disposed | 20.81 | 2,808.96 | Form 4, filing 0001209191-14-056984 | |
| 2014-08-25 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 5,265 disposed | 20.81 | 109,549.38 | Form 4, filing 0001209191-14-056984 | |
| 2014-08-25 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 5,265 disposed | 20.81 | 109,549.38 | Form 4, filing 0001209191-14-054681 | |
| 2014-08-25 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 135 disposed | 20.81 | 2,808.96 | Form 4, filing 0001209191-14-054681 | |
| 2014-08-22 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 42 disposed | 20.56 | 863.44 | Form 4, filing 0001209191-14-056983 | |
| 2014-08-22 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 1,658 disposed | 20.56 | 34,085.33 | Form 4, filing 0001209191-14-056983 | |
| 2014-08-22 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 1,658 disposed | 20.56 | 34,085.33 | Form 4, filing 0001209191-14-054494 | |
| 2014-08-22 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 42 disposed | 20.56 | 863.44 | Form 4, filing 0001209191-14-054494 | |
| 2014-06-24 |
Ardelyx, Inc. ARDX |
P, Open-market purchase | 308,905 acquired | 14.00 | 4,324,670.00 | Form 4, filing 0001209191-14-043776 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Presidio Partners 2007, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001405712
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6